Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease

West African Journal of Medicine

Volumn 24, Issue 2, 2005, Pages 120-123

  Oladipo, O O ^a   Temiye, E O ^a   Ezeaka, V C ^a   Obomanu, P ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Calcium; Magnesium; Phosphorus; Sickle cell disease

Indexed keywords

ALBUMIN; CALCIUM; HEMOGLOBIN A; HEMOGLOBIN S; MAGNESIUM; PHOSPHATE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BINDING; CALCIUM BLOOD LEVEL; CHILD; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HEMOGLOBIN AA; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SS; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; INFANT; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; NIGERIA; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

EID: 23044499509     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: 10.4314/wajm.v24i2.28180     Document Type: Article

References (32)

1. Herrick JB. Perculiar elongated and sickle shaped red blood corpuscles in a case of severe anaemia. Arch Intern Med 1910;6:517-521.
2. Haemoglobinopathies S,C,D,E and O and associated diseases. In: Winthrobe MM (ed): Clinical Haematology. 7th edition, Philadelphia, Lea and Febiger. 1974: 828
3. Serjearnt GR. Sickle cell disease. 2nd edition, New York, Oxford University Press. 1992:23-25.
4. Flemming AF, Storey JL, Molineaux E, Iroko A and Atai ED. Abnormal haemoglobins in the Sudan Savannah of Nigeria. Ann Trop Med Parasit. 1979;73:161-168.
5. Ohaeri JU, Shokunbi WA. Attitudes and beliefs of relatives of patients with sickle cell disease. East Afr Med J 2001; 78:174-179.
6. Jacob JF. A study of the survival rate of cases of sickle cell anaemia. Br Med J 1957;1;738-739.
7. Shaper AG, Sharper L. analysis of medical admissions to Mulago hospital. East Afr Med J 1958;35: 647-678.
8. Nils-Erik LS, Eero M, Heikki K, Jahangir AK, Andrzei L. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294:1-26.
9. Nduka N, Kazem Y, Saleh B. Variations in serum electrolytes and enzyme concentrations in patients with sickle cell disease. J Clin Path 1995;48:648-51.
10. 2+ATPase and Ca-Binding Properties of Sickle Red Cell Membranes. Am J Hem 1980;8:377-387.
11. Olukoga AO, Adewoye HO, Erasmus RT, Adedoyin MA. Urinary magnesium excretion in steady state sickle cell anaemia. Acta Haematol 1993;90:136-138.
12. Akenami FOT, Aken'Ova YA, Osifo BO. Serum zinc, copper and magnesium in sickle cell disease at Ibadan, South Western Nigeria. Afr J Med med Sci 1999;28:137-139.
13. Smith CE, Valika KS, Woo JE, O'Donnell JG, Gordon DL, Westerman MP. Serum phosphate abnormalities in sickle cell disease. Proceedings of the Society for Experimental Biology and Medicine. 1981;168:254-258.
14. Al Harbi N, Annobil SH, Abbag F, Adzaku F, Bassuni W. Renal re-absorption of phosphate in children with sickle cell anaemia. Am J Nephrol 1999;19:552-554.
15. Tietz NW. Ed. Clinical guide to laboratory tests. Philadelphia, WB Saunders company, 1983.
16. Benga I, Baltescu V, Tilinca R, Pavel O.,Ghiran V., Muschevici D., Benga G. Plasma and cerebrospinal fluid concentrations of magnesium in epileptic children. J Neurol Sci 1985;67:29-34.
17. Kazmierczak SC. Magnesium In: Kaplan LA, Pesce AJ (Eds.) Clinical Chemistry: theory, analysis, corelation. 3rd edition. Philadelphia, Mosby company. 1996; 550-551.
18. Lorentz K. Improved determination of serum calcium with o-cresolphthalein complexone. Clin Chem Acta 1982; 126:327-334.
19. Kaplan A, Szabo LL, Opheim KE. (Eds.) Clinical Chemistry: Interpretation and Techniques. 3rd Edition. Philadelphia, Lea and Febiger Company. 1983; p324-325.
20. Peters T, Biamonte GT. Protein in serum, urine and CSF: Albumin in serum. In: Faulkner WR, Meites S. (Eds.) Selected Methods of Clinical Chemistry. Washington D.C. 1982; 317.
21. Reinhart MD. Magnesium metabolism: A review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 1988;148:2415-2420.
22. Milne DB. Trace Elements In: Burtis CA and Ashwood RE. (Eds) Teitz Textbook of Clinical Chemistry. 3rd ed Philadelphia WB Saunders company 1999; p1034.
23. De Francheschi L, Bachir D, Galacteros F, Tchernia G, Cynober T, Neuberg D, Beuzard Y, Brugnara C. Oral magnesium pidolate: effects of long term administration in patients with sickle cell disease. Br J Haematol 2000;108:284-289.
24. Olukoga AO, Adewoye HO, Erasmus RT, Adedoyin MA. Erythrocyte and plasma magnesium in sickle cell anaemia. East Afr Med J 1990;67:348-354.
25. Prasad A, Ortega J, Brewer GJ, Oberleas D, Schoomaker EB. Trace elements in sickle cell disease. JAMA 1976;235:2396-2398.
26. De Francheschi L, Bachir D, Galacteros F, Tchernia G, Cynober T, Alper S, Platt O, Beuzard Y, Brugnara C. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1997; 100: 1847-1852.
27. Nduka N, Ekeke GI. Serum calcium and protein in Haemoglobin SS patients. Folia Haematol 1987;114:508-511.
28. Muhammed S, Addae S, Suleiman S, Adzaku F, Annobil S, kaddoumi O, Richards J. Serum calcium, parathyroid hormone and vitamin D status in children and young adults with sickle cell disease. Ann Clin Biochem 1993; 30:45-51.
29. + ATPase Activities in erythrocytes of sickle cell anaemia. Blood 1982;60:1332-1336.
30. Ekeke GI, Anosike EO, Ibeh GO, Uwakwe AA, Monanu MO. Some biochemical changes induced by the antisickling nutrients: phenylalanine, Cajanus Cajan extract and sicklervit. Clin Chem 1991;37:951.
31. Joiner CH. Cation transport and volume regulation in sickle red blood cells. Am Physiol Society 1993:C250-C270.
32. Rezaei-Kalantari H. Comment Je Une drepanocytose: actualites therapeutiques [How I treat sickle cell anaemia: current therapies] Rev Med Liege 2001; 56:671-5.